Skip to content

Drug interactions

Ergotamine + Glofitamab

Severity: Major

Ergotamine and Glofitamab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glofitamab induces cytokine release that may transiently suppress CYP3A4 activity. Ergotamine exposure may rise, raising the risk of ergotism and ischemia.

What this interaction means in plain words

Ergotamine and Glofitamab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ergotamine belongs to Central Nervous System; Glofitamab belongs to Oncology.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP3A4 reduces ergotamine clearance.

What to do

Avoid ergotamine during the first cycles of glofitamab and during cytokine release syndrome. If unavoidable, monitor for vasospastic symptoms.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ergotamine and Glofitamab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ergotamine with Glofitamab?

MediHelp rates the interaction as major. Ergotamine and Glofitamab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Glofitamab induces cytokine release that may transiently suppress CYP3A4 activity. Ergotamine exposure may rise, raising the risk of ergotism and ischemia.

How serious is the interaction between Ergotamine and Glofitamab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid ergotamine during the first cycles of glofitamab and during cytokine release syndrome. If unavoidable, monitor for vasospastic symptoms.

What other medicines interact with Ergotamine?

MediHelp also lists interactions of Ergotamine with, for example, Almotriptan, Atazanavir, Clarithromycin. The full list is on the Ergotamine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in